{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:20:58Z","timestamp":1792189258520,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"crossref","award":["APVV-0887-11"],"award-info":[{"award-number":["APVV-0887-11"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"crossref","award":["APVV-15-0685"],"award-info":[{"award-number":["APVV-15-0685"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science Grant Agency","award":["1\/0294\/15"],"award-info":[{"award-number":["1\/0294\/15"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejphar.2016.08.040","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T17:49:00Z","timestamp":1473443340000},"page":"244-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Ramipril restores PPAR\u03b2\/\u03b4 and PPAR\u03b3 expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat"],"prefix":"10.1016","volume":"791","author":[{"given":"Hana","family":"Cernecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Doka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Srankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Pivackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Malikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Galkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kyselovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Krenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Klimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.08.040_bib1","doi-asserted-by":"crossref","first-page":"e46126","DOI":"10.1371\/journal.pone.0046126","article-title":"Inhibition of doxorubicin-induced senescence by PPARdelta activation agonists in cardiac muscle cells: cooperation between PPARdelta and Bcl6","volume":"7","author":"Altieri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2016.08.040_bib2","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1210\/en.2006-0728","article-title":"Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes","volume":"147","author":"Aragno","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2016.08.040_bib3","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/1097-0142(19920315)69:6<1492::AID-CNCR2820690630>3.0.CO;2-3","article-title":"Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects","volume":"69","author":"Bauch","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2016.08.040_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib5","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMcibr022472","article-title":"Angiotensin-converting enzyme 2--a new cardiac regulator","volume":"347","author":"Boehm","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2016.08.040_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/CT:3:4:319","article-title":"Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity","volume":"3","author":"Boucek","year":"2003","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1006\/jmcc.1999.0972","article-title":"Persistent effects of doxorubicin on cardiac gene expression","volume":"31","author":"Boucek","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-2828(89)91497-1","article-title":"Reduction of myofibrillar ATPase activity and isomyosin shift in delayed doxorubicin cardiotoxicity","volume":"21","author":"Cappelli","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejphar.2013.06.040","article-title":"Enalaprilat increases PPARbeta\/delta expression, without influence on PPARalpha and PPARgamma, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy","volume":"714","author":"Cernecka","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1116","article-title":"Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy","volume":"10","author":"Cheng","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2016.08.040_bib12","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0026-895X(24)23224-7","article-title":"Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment","volume":"57","author":"de Beer","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib13","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2016.08.040_bib14","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice","volume":"97","author":"Duan","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/01.RES.73.1.184","article-title":"Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding","volume":"73","author":"Feldman","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.RES.87.3.241","article-title":"Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure","volume":"87","author":"Ferdinandy","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1096\/fj.03-0724rev","article-title":"The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage","volume":"18","author":"Fogli","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2016.08.040_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1113\/expphysiol.2013.077594","article-title":"Effects of a sucrose-enriched diet on the pattern of gene expression, contraction and Ca(2+) transport in Goto-Kakizaki type 2 diabetic rat heart","volume":"99","author":"Gaber","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib20","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jtcvs.2010.07.097","article-title":"Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function","volume":"142","author":"Hiona","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejphar.2016.08.040_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1742-7843.2012.00901.x","article-title":"Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension","volume":"111","author":"Klimas","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ptr.3015","article-title":"Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats","volume":"24","author":"Klimas","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","article-title":"Heart rate correction of the QT duration in rats","volume":"641","author":"Kmecova","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/eurjhf\/hfn026","article-title":"Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function","volume":"11","author":"Krenek","year":"2009","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.ejphar.2016.08.040_bib26","first-page":"1280","article-title":"Unbalanced upregulation of ryanodine receptor 2 plays a particular role in early development of daunorubicin cardiomyopathy","volume":"7","author":"Kucerova","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib27","doi-asserted-by":"crossref","first-page":"e96055","DOI":"10.1371\/journal.pone.0096055","article-title":"Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up","volume":"9","author":"Lencova-Popelova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2016.08.040_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2016.08.040_bib29","doi-asserted-by":"crossref","first-page":"e0121007","DOI":"10.1371\/journal.pone.0121007","article-title":"G\u03b1q protein carboxyl terminus imitation polypeptide GCIP-27 improves cardiac function in chronic heart failure rats","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2016.08.040_bib30","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1517\/14740338.2011.589834","article-title":"Anthracycline cardiotoxicity","volume":"11","author":"Menna","year":"2012","journal-title":"Expert. Opin. Drug. Saf."},{"key":"10.1016\/j.ejphar.2016.08.040_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.1999.00480.x","article-title":"QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma","volume":"245","author":"Nousiainen","year":"1999","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2016.08.040_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2796.2002.00951.x","article-title":"Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction","volume":"251","author":"Nousiainen","year":"2002","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2016.08.040_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1476-5381.1996.tb15326.x","article-title":"Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention","volume":"117","author":"Pouna","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxlet.2010.10.017","article-title":"Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy","volume":"200","author":"Shuai","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2016.08.040_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2016.08.040_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2016.08.040_bib37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.RES.82.10.1029","article-title":"Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation","volume":"82","author":"Sugiura","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2016.08.040_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/14728222.2010.512917","article-title":"PPARs as therapeutic targets in cardiovascular disease","volume":"14","author":"van Bilsen","year":"2010","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2016.08.040_bib39","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/me.2009-0115","article-title":"The trafficking\/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production","volume":"23","author":"Wang","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2016.08.040_bib40","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin","volume":"61","author":"Zhou","year":"2001","journal-title":"Cancer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916305593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916305593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:55:04Z","timestamp":1749578104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916305593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0014299916305593"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.08.040","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ramipril restores PPAR\u03b2\/\u03b4 and PPAR\u03b3 expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}